AlzChem Group AG (XETRA:ACT) — Market Cap & Net Worth
Market Cap & Net Worth: AlzChem Group AG (ACT)
AlzChem Group AG (XETRA:ACT) has a market capitalization of $1.83 Billion (€1.56 Billion) as of May 2, 2026. Listed on the XETRA stock exchange, this Germany-based company holds position #6621 globally and #966 in its home market, demonstrating a -9.84% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying AlzChem Group AG's stock price €165.90 by its total outstanding shares 10123706 (10.12 Million). Review ACT total liabilities to assess the company's total debt and financial obligations.
AlzChem Group AG Market Cap History: 2015 to 2026
AlzChem Group AG's market capitalization history from 2015 to 2026. Data shows change from $1.88 Billion to $1.96 Billion (-5.09% CAGR).
AlzChem Group AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how AlzChem Group AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.26x
AlzChem Group AG's market cap is 3.26 times its annual revenue
Latest Price to Earnings (P/E) Ratio
28.91x
AlzChem Group AG's market cap is 28.91 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.36 Billion | $327.19 Million | -$28.75K | 4.16x | N/A |
| 2017 | $258.52 Million | $353.92 Million | $20.39 Million | 0.73x | 12.68x |
| 2018 | $208.09 Million | $375.22 Million | $22.64 Million | 0.55x | 9.19x |
| 2019 | $209.31 Million | $376.07 Million | $17.98 Million | 0.56x | 11.64x |
| 2020 | $216.67 Million | $379.26 Million | $19.69 Million | 0.57x | 11.00x |
| 2021 | $244.51 Million | $422.29 Million | $27.59 Million | 0.58x | 8.86x |
| 2022 | $184.84 Million | $542.22 Million | $30.05 Million | 0.34x | 6.15x |
| 2023 | $299.41 Million | $540.65 Million | $34.62 Million | 0.55x | 8.65x |
| 2024 | $674.63 Million | $554.23 Million | $54.08 Million | 1.22x | 12.48x |
| 2025 | $1.83 Billion | $562.12 Million | $63.46 Million | 3.26x | 28.91x |
Competitor Companies of ACT by Market Capitalization
Companies near AlzChem Group AG in the global market cap rankings as of May 2, 2026.
Key companies related to AlzChem Group AG by market ranking:
- Linde plc Ordinary Shares (NASDAQ:LIN): Ranked #91 globally with a market cap of $210.18 Billion USD.
- Air Liquide SA (PA:AI): Ranked #222 globally with a market cap of $108.00 Billion USD ( €92.38 Billion EUR).
- AIR LIQUIDE ADR 1/5/EO 11 (F:AILA): Ranked #232 globally with a market cap of $103.86 Billion USD ( €88.84 Billion EUR).
- Sherwin-Williams Co (NYSE:SHW): Ranked #334 globally with a market cap of $78.83 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #91 | Linde plc Ordinary Shares | NASDAQ:LIN | $210.18 Billion | $507.92 |
| #222 | Air Liquide SA | PA:AI | $108.00 Billion | €183.08 |
| #232 | AIR LIQUIDE ADR 1/5/EO 11 | F:AILA | $103.86 Billion | €36.60 |
| #334 | Sherwin-Williams Co | NYSE:SHW | $78.83 Billion | $318.00 |
AlzChem Group AG Historical Marketcap From 2015 to 2026
Between 2015 and today, AlzChem Group AG's market cap moved from $1.88 Billion to $ 1.96 Billion, with a yearly change of -5.09%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.96 Billion | +7.03% |
| 2025 | €1.83 Billion | +171.93% |
| 2024 | €674.63 Million | +125.32% |
| 2023 | €299.41 Million | +61.98% |
| 2022 | €184.84 Million | -24.40% |
| 2021 | €244.51 Million | +12.85% |
| 2020 | €216.67 Million | +3.51% |
| 2019 | €209.31 Million | +0.59% |
| 2018 | €208.09 Million | -19.51% |
| 2017 | €258.52 Million | -81.01% |
| 2016 | €1.36 Billion | -27.62% |
| 2015 | €1.88 Billion | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of AlzChem Group AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.83 Billion USD |
| MoneyControl | $1.83 Billion USD |
| MarketWatch | $1.83 Billion USD |
| marketcap.company | $1.83 Billion USD |
| Reuters | $1.83 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About AlzChem Group AG
AlzChem Group AG, together with its subsidiaries, develops, produces, and markets a range of chemical specialties in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The Specialty Chemicals segment sells specialty chemical products that are used in the chemical, f… Read more